Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs ...

Vertex Pharmaceuticals’ short interest has dropped by 22.32%, now sitting at 1.74% of its float—Wall Street seems less pessimistic. Short interest reflects how many shares are being bet against and ...

This repository is a collection of reference implementations for the Model Context Protocol (MCP), as well as references to community built servers and additional resources. The servers in this ...

Now in preview, the latest Flash lets you adjust reasoning capabilities to balance cost and complexity. Here's how to try it ...

Google Cloud's updated its Vertex AI platform to support AI agents with including the Agent Development Kit, the Agent2Agent ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. It recently won approval for a non-opioid pain ...

Artists featured in the Converge+Vertex exhibit at Barrett Gallery shared a transcendent conversation at a panel hosted by ...

Vega Datasets is the centralized hub for over 70 datasets featured in the examples and documentation of Vega, Vega-Lite, Altair and related projects. A dataset catalog conforming to the Data Package ...

The report of the KT Chitrasiri Committee on trimming fat off the political establishment is in though not published. The government seems seriously intent on setting a good example and correcting ...

Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...

Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the Phase 1/2/3 study in patients with T1D with severe ...